NAA50

Chr 3

N-alpha-acetyltransferase 50, NatE catalytic subunit

Also known as: MAK3, NAT13, NAT13P, NAT5, NAT5P, SAN, hNaa50p

NAA50 encodes an N-terminal acetyltransferase that acetylates the amino terminus of proteins retaining their initiating methionine and functions as part of the NatA complex, playing a critical role in sister chromatid cohesion during mitosis. The gene is highly constrained against loss-of-function variants (LOEUF 0.545), but specific disease associations and inheritance patterns have not been established from the provided data. Further clinical and genetic studies are needed to define the phenotypic spectrum associated with NAA50 variants.

OMIMResearchSummary from RefSeq, UniProt
LOEUF 0.55
Clinical SummaryNAA50
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.73) — some intolerance to loss-of-function variants.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.55LOEUF
pLI 0.735
Z-score 2.42
OE 0.11 (0.040.55)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
1.78Z-score
OE missense 0.46 (0.360.60)
40 obs / 86.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.11 (0.040.55)
00.351.4
Missense OE0.46 (0.360.60)
00.61.4
Synonymous OE1.01
01.21.6
LoF obs/exp: 1 / 8.7Missense obs/exp: 40 / 86.6Syn Z: -0.05

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

NAA50 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 2 results · since 2015Search PubMed ↗